CRISPR-CAS9 ribonucleoprotein

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Cells1

Outcomes

3

Pcsk9 gene disruption

upin mice1+1.4% total hepatic gene disruption

1 study
  1. CRISPR-CAS9 ribonucleoprotein induces pcsk9 gene disruption in mice (1.39% total hepatic gene disruption).

    “Systemic administration of LNPC12A9 into C57BL/6J mice led to liver tropism and a total hepatic Pcsk9 gene disruption rate of 1.39%.”

    AnimalsC57BL/6J miceLNPC12A9liver

    High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing

    ACS applied materials & interfaces16 Oct 2026

homology-directed repair

upin cells1+38% hdr rate

1 study
  1. CRISPR-CAS9 ribonucleoprotein induces homology-directed repair in cells (37.8% HDR rate).

    “coencapsulation of RNP and a single-stranded oligodeoxynucleotide (ssODN) template for homology-directed repair (HDR) within LNPC12A9 induced an HDR rate of 37.8%.”

    CellsRNP and ssODN template coencapsulated within LNPC12A9

    High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing

    ACS applied materials & interfaces16 Oct 2026

EGFP disruption

upin human cells1

1 study
  1. CRISPR-CAS9 ribonucleoprotein induces EGFP disruption in human cells (∼90% disruption at 30 nM; ∼60% at 15 nM).

    “achieved ∼90% EGFP disruption in HEK293T-EGFP cells at an RNP concentration of 30 nM and ∼60% at 15 nM.”

    CellsLNPC12A9HEK293T-EGFP cells30 nM and 15 nM RNP

    High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing

    ACS applied materials & interfaces16 Oct 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months